Charting the global footprint of borderline oxacillin-resistant Staphylococcus aureus (BORSA): the first systematic review and meta-analysis
2024

Global Prevalence of Borderline Oxacillin-Resistant Staphylococcus aureus (BORSA)

Sample size: 18781 publication Evidence: high

Author Information

Author(s): Engku Abd Rahman Engku Nur Syafirah, Irekeola Ahmad Adebayo, Yamin Dina, Elmi Abdirahman Hussein, Chan Yean Yean

Hypothesis

What is the global prevalence of borderline oxacillin-resistant Staphylococcus aureus (BORSA)?

Conclusion

The study found a global BORSA prevalence of 6.6%, with significant regional variations.

Supporting Evidence

  • The highest prevalence of BORSA was found in animals at 46.3%.
  • Brazil had the highest prevalence at 70.0%, while The Netherlands had the lowest at 0.5%.
  • The study included data from 29 studies with a total of 18,781 samples.
  • Substantial heterogeneity was observed among the studies (I2 = 96.802%).
  • Improved reporting practices and tailored surveillance protocols are needed.

Takeaway

BORSA is a type of bacteria that is hard to treat because it resists some antibiotics, and it is found in people, animals, and food.

Methodology

This study is a systematic review and meta-analysis that aggregated data from 29 studies.

Potential Biases

Potential publication bias was indicated, but it was not statistically significant.

Limitations

The study's findings may be influenced by the variability in methodologies and sample sources across the included studies.

Participant Demographics

Data were collected from 29 studies across 19 countries, including samples from humans, food, and animals.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI [4.0–10.7]

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.7717/peerj.18604

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication